Bixiye
Upcoming policies effective May 2_ 2022.pdf
Natiijooyinka Raadinta
Soo bandhiga 2661 - 2670 ee natiijooyinka 4130
Bixiye
QP16-22 Reminder: Prior Authorization Waivers Ending February 28, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 23, Feb 2022
Bixiye
QP14-22 COVID-19 Vaccination Reminders for Providers
Taariikhda uu dhaqangalayo Barnaamijka: 23, Feb 2022
Bixiye
QP15-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 14, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 23, Feb 2022
Bixiye
QP8-22 Anthem Blue Cross Change to City of New York Retirees
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP9-22 Timely Filing Denials for COVID-19 Testing and Immunizations
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP10-22 Commercial Pharmacy Benefit Exclusion for Basaglar®
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP11-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Bixiye
QP12-22 MHCP Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022